Brazilian ibd study group position statement on sars-cov2 vaccination

Detalhes bibliográficos
Autor(a) principal: Queiroz, Natália Sousa Freitas
Data de Publicação: 2021
Outros Autores: Teixeira, Fábio Vieira, Freire, Caio Cesar Furtado, Motta, Marina Pamponet, De Vasconcellos, Marcela Almeida Menezes, Chebli, Liliana Andrade, Hossne, Rogerio Saad [UNESP]
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Repositório Institucional da UNESP
Texto Completo: http://dx.doi.org/10.1590/s0004-2803.202100000-02
http://hdl.handle.net/11449/208634
Resumo: Mass vaccination offers the best strategy to fight against COVID-19 pandemic, and SARS-CoV2 vaccines are being approved in several countries for emergency use. In Brazil, vaccine approval is expected in the next few days, however potential concerns exist regarding vaccine recommendations for specific populations, such as patients with inflammatory bowel disease (IBD). To address these questions, the Brazilian IBD Study Group (GEDIIB) provides this practical advice with key recommendations about the COVID-19 vaccines in IBD population.
id UNSP_72d9a635484321b003fb5ba3979c706f
oai_identifier_str oai:repositorio.unesp.br:11449/208634
network_acronym_str UNSP
network_name_str Repositório Institucional da UNESP
repository_id_str 2946
spelling Brazilian ibd study group position statement on sars-cov2 vaccinationPosicionamento do Grupo de Estudos da Doença Inflamatória Intestinal do Brasil sobre a vacinação para SARS-CoV2Mass vaccination offers the best strategy to fight against COVID-19 pandemic, and SARS-CoV2 vaccines are being approved in several countries for emergency use. In Brazil, vaccine approval is expected in the next few days, however potential concerns exist regarding vaccine recommendations for specific populations, such as patients with inflammatory bowel disease (IBD). To address these questions, the Brazilian IBD Study Group (GEDIIB) provides this practical advice with key recommendations about the COVID-19 vaccines in IBD population.Departamento de Gastroenterologia Faculdade de Medicina da Universidade de São PauloGastrosaúde – Clínica IBDHospital Geral Cesar CalsUniversidade Federal da Bahia Faculdade de MedicinaUniversidade Federal de Sergipe Departamento de MedicinaUniversidade Federal de Juiz de Fora (UFJF) Clínicas ambulatoriais IBDUniversidade Estadual Paulista (UNESP) Faculdade de Medicina de BotucatuUniversidade Estadual Paulista (UNESP) Faculdade de Medicina de BotucatuUniversidade de São Paulo (USP)Gastrosaúde – Clínica IBDHospital Geral Cesar CalsUniversidade Federal da Bahia (UFBA)Universidade Federal de Sergipe (UFS)Clínicas ambulatoriais IBDUniversidade Estadual Paulista (Unesp)Queiroz, Natália Sousa FreitasTeixeira, Fábio VieiraFreire, Caio Cesar FurtadoMotta, Marina PamponetDe Vasconcellos, Marcela Almeida MenezesChebli, Liliana AndradeHossne, Rogerio Saad [UNESP]2021-06-25T11:15:20Z2021-06-25T11:15:20Z2021-01-01info:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/article2-4http://dx.doi.org/10.1590/s0004-2803.202100000-02Arquivos de Gastroenterologia, v. 58, n. 1, p. 2-4, 2021.1678-42190004-2803http://hdl.handle.net/11449/20863410.1590/s0004-2803.202100000-022-s2.0-85105083787Scopusreponame:Repositório Institucional da UNESPinstname:Universidade Estadual Paulista (UNESP)instacron:UNESPengArquivos de Gastroenterologiainfo:eu-repo/semantics/openAccess2024-08-14T14:18:15Zoai:repositorio.unesp.br:11449/208634Repositório InstitucionalPUBhttp://repositorio.unesp.br/oai/requestopendoar:29462024-08-14T14:18:15Repositório Institucional da UNESP - Universidade Estadual Paulista (UNESP)false
dc.title.none.fl_str_mv Brazilian ibd study group position statement on sars-cov2 vaccination
Posicionamento do Grupo de Estudos da Doença Inflamatória Intestinal do Brasil sobre a vacinação para SARS-CoV2
title Brazilian ibd study group position statement on sars-cov2 vaccination
spellingShingle Brazilian ibd study group position statement on sars-cov2 vaccination
Queiroz, Natália Sousa Freitas
title_short Brazilian ibd study group position statement on sars-cov2 vaccination
title_full Brazilian ibd study group position statement on sars-cov2 vaccination
title_fullStr Brazilian ibd study group position statement on sars-cov2 vaccination
title_full_unstemmed Brazilian ibd study group position statement on sars-cov2 vaccination
title_sort Brazilian ibd study group position statement on sars-cov2 vaccination
author Queiroz, Natália Sousa Freitas
author_facet Queiroz, Natália Sousa Freitas
Teixeira, Fábio Vieira
Freire, Caio Cesar Furtado
Motta, Marina Pamponet
De Vasconcellos, Marcela Almeida Menezes
Chebli, Liliana Andrade
Hossne, Rogerio Saad [UNESP]
author_role author
author2 Teixeira, Fábio Vieira
Freire, Caio Cesar Furtado
Motta, Marina Pamponet
De Vasconcellos, Marcela Almeida Menezes
Chebli, Liliana Andrade
Hossne, Rogerio Saad [UNESP]
author2_role author
author
author
author
author
author
dc.contributor.none.fl_str_mv Universidade de São Paulo (USP)
Gastrosaúde – Clínica IBD
Hospital Geral Cesar Cals
Universidade Federal da Bahia (UFBA)
Universidade Federal de Sergipe (UFS)
Clínicas ambulatoriais IBD
Universidade Estadual Paulista (Unesp)
dc.contributor.author.fl_str_mv Queiroz, Natália Sousa Freitas
Teixeira, Fábio Vieira
Freire, Caio Cesar Furtado
Motta, Marina Pamponet
De Vasconcellos, Marcela Almeida Menezes
Chebli, Liliana Andrade
Hossne, Rogerio Saad [UNESP]
description Mass vaccination offers the best strategy to fight against COVID-19 pandemic, and SARS-CoV2 vaccines are being approved in several countries for emergency use. In Brazil, vaccine approval is expected in the next few days, however potential concerns exist regarding vaccine recommendations for specific populations, such as patients with inflammatory bowel disease (IBD). To address these questions, the Brazilian IBD Study Group (GEDIIB) provides this practical advice with key recommendations about the COVID-19 vaccines in IBD population.
publishDate 2021
dc.date.none.fl_str_mv 2021-06-25T11:15:20Z
2021-06-25T11:15:20Z
2021-01-01
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://dx.doi.org/10.1590/s0004-2803.202100000-02
Arquivos de Gastroenterologia, v. 58, n. 1, p. 2-4, 2021.
1678-4219
0004-2803
http://hdl.handle.net/11449/208634
10.1590/s0004-2803.202100000-02
2-s2.0-85105083787
url http://dx.doi.org/10.1590/s0004-2803.202100000-02
http://hdl.handle.net/11449/208634
identifier_str_mv Arquivos de Gastroenterologia, v. 58, n. 1, p. 2-4, 2021.
1678-4219
0004-2803
10.1590/s0004-2803.202100000-02
2-s2.0-85105083787
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv Arquivos de Gastroenterologia
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv 2-4
dc.source.none.fl_str_mv Scopus
reponame:Repositório Institucional da UNESP
instname:Universidade Estadual Paulista (UNESP)
instacron:UNESP
instname_str Universidade Estadual Paulista (UNESP)
instacron_str UNESP
institution UNESP
reponame_str Repositório Institucional da UNESP
collection Repositório Institucional da UNESP
repository.name.fl_str_mv Repositório Institucional da UNESP - Universidade Estadual Paulista (UNESP)
repository.mail.fl_str_mv
_version_ 1808128103401127936

Registros relacionados